We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

58 hedge funds and large institutions have $23.7M invested in IVERIC bio, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $22.6M → $23.7M (+$1.13M)

8% less funds holding

Funds holding: 6358 (-5)

15% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 20

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
58
Holders Change
-5
Holders Change %
-7.94%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
6
Increased
17
Reduced
20
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$5.75M +$3.7K +2,643 +0.1%
TA
2
Tamarack Advisers
California
$4.23M +$2.8M +2,000,000 +200%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$1.66M +$118K +84,127 +8%
Renaissance Technologies
4
Renaissance Technologies
New York
$1.57M +$522K +373,551 +51%
Morgan Stanley
5
Morgan Stanley
New York
$1.37M -$18.2K -13,024 -1%
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.31M +$401K +286,411 +45%
Connor, Clark & Lunn Investment Management (CC&L)
7
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.23M -$11.7K -8,400 -1%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$962K -$2.57M -1,839,434 -73%
BlackRock
9
BlackRock
New York
$943K -$7.34K -5,248 -0.8%
TCM
10
Tang Capital Management
California
$846K
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$516K -$616K -440,510 -55%
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$448K +$112K +80,400 +34%
SIM
13
Spark Investment Management
New York
$346K -$143K -101,900 -29%
Two Sigma Investments
14
Two Sigma Investments
New York
$328K +$83.5K +59,691 +34%
Deutsche Bank
15
Deutsche Bank
Germany
$309K +$95.5K +68,300 +45%
BCM
16
Bridgeway Capital Management
Texas
$307K
Geode Capital Management
17
Geode Capital Management
Massachusetts
$245K
JP Morgan Chase
18
JP Morgan Chase
New York
$215K +$78.5K +56,160 +58%
Northern Trust
19
Northern Trust
Illinois
$123K -$130 -93 -0.1%
SXL
20
Summit X LLC
Missouri
$112K -$6.29K -4,500 -5%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$79K -$1.26K -900 -2%
Creative Planning
22
Creative Planning
Kansas
$77K +$903 +646 +1%
Millennium Management
23
Millennium Management
New York
$76K +$75.2K +53,766 New
Wells Fargo
24
Wells Fargo
California
$72K +$15.7K +11,239 +28%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$61K

ISEE Hedge Fund Activity: Q1 2019 in Review

58 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2019, worth a combined $23.7M — up 5% from $22.6M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of ISEE and 6 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 17 added.

The largest buyer was Tamarack Advisers, adding an estimated $2.8M. The largest seller was D.E. Shaw & Co, cutting an estimated $2.57M.

  • 58 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2019, down from 63 in Q4 2018.
  • Funds reported $23.7M of IVERIC bio, Inc. Common Stock stock for Q1 2019, up 5% quarter-over-quarter.
  • 6 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2019 and 11 closed out, a net change of -5 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q1 2019 was Tamarack Advisers, an estimated $2.8M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q1 2019 was D.E. Shaw & Co, an estimated $2.57M sold.

Based on aggregated 13F filings for Q1 2019.